cse: ORIG*
There’s a bright future in
psychedelic therapeutic treatments.
Supported by science, we see the opportunity to support innovators as they bring these new psychedelic treatments to market.
*Proposed stock ticker.
Stay Updated
By subscribing, you agree to receive emails from Origin. You may choose to unsubscribe at any time
A Global Psychedelic-Focused Investment Opportunity
Origin Therapeutics is an actively-managed investment issuer providing investors with a diverse exposure to the psychedelic industry.
H
Human-Focused
The industry developing now has the potential for more than just profitable investments: it’s a way to further treatment in mental health. We’re investing in a diverse portfolio with one commonality: the betterment of all of us.
E
Expertise
Knowing the market, is winning the market. Our in-house expertise and relationships with industry specialists allows us to make decisions from a position of strength.
A
Access
Brokering partnerships with key players gives us VIP access to exclusive opportunities not available to the public.
L
Leadership
The most important asset we have is our team. This powerhouse group brings the insight, analysis, and executive skill backed by decades of successful multi-billion dollar projects.
Our Investment Strategy
We focus on companies with an exemplary management team and exponential growth profile.